Default Category
-
CanniMed Therapeutics Inc.: The IPO Dilemma
Adam Fremeth; Zhou Zhang; Dean PopilCase IVEY-W26387-EFinance, StrategyIn November 2016, the chief executive officer of CanniMed Therapeutics Inc. was considering the company’s options for raising capital through an initial public offering. The decision was critical for the Saskatchewan-based medical cannabis company, whichStarting at €8.20